Medical Condition News

RSS

Current research does not support use of smell tests for Alzheimer's dementia

Current research does not support the use of smell tests for predicting Alzheimer's dementia, according to a comprehensive review by Robert Wood Johnson Foundation Clinical Scholars at the University of Michigan and the VA Center for Clinical Management Research.

4 May 2012

Abbott to purchase AP214 hormone analogue from Action Pharma

Abbott and Action Pharma A/S, a privately owned company, today announced that they have entered into an agreement in which Abbott will acquire AP214 from Action Pharma.

4 May 2012

Health care quality varies widely despite high spending in the U.S.

The United States spends more on health care than 12 other industrialized countries yet does not provide "notably superior" care, according to a new study from The Commonwealth Fund.

4 May 2012

Researchers create new systematic assessment for malnutrition

A new systematic assessment of malnutrition, created by researchers at Penn State, will aid dietitians and other health care providers in diagnosis and treatment.

4 May 2012

Clinical trial to investigate statins in patients with acute severe respiratory failure

Queen's University and NUI Galway and are leading a clinical trial to investigate the possibility that statins, a drug commonly used to combat cholesterol, might help patients with acute severe respiratory failure.

4 May 2012

New genetic pathway influences spread of cancer cells

In a new study from Lawson Health Research Institute, Dr. Joseph Torchia has identified a new genetic pathway influencing the spread of cancer cells. The discovery of this mechanism could lead to new avenues for treatment.

4 May 2012

Varenicline reduces alcohol intake among heavy-drinking smokers

The smoking cessation drug varenicline significantly reduced alcohol consumption in a group of heavy-drinking smokers, in a study carried out by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.

4 May 2012

Lexicon to receive funding for LX4211 Phase 2 trial in type 1 diabetes

Lexicon Pharmaceuticals, Inc. announced today that an independent, non-profit organization will provide funding to support the Phase 2 development of LX4211 in type 1 diabetes.

4 May 2012

Comorbidities common among patients with COPD

Comorbidities are common among patients with chronic obstructive pulmonary disease (COPD), and a number of these comorbidities are independently associated with an increased mortality risk, according to a new study.

4 May 2012

Researchers identify switches that can turn on or off genes associated with colorectal cancer

Two researchers at the Geisel School of Medicine at Dartmouth have helped to identify switches that can turn on or off genes associated with colorectal cancer. The finding offers clues about the development of colorectal cancer and could-potentially-provide targets for new therapies.

4 May 2012

AHA, ASA honor Cedars-Sinai’s Stroke Program with Gold Award

Cedars-Sinai Medical Center's Stroke Program was spotlighted by the American Heart Association/American Stroke Association April 18 for earning the highest achievement in the association's initiative to improve outcomes for patients suffering strokes: the Get With the Guidelines Gold Plus award.

4 May 2012

IGF-axis proteins may have a role in development of type 2 diabetes

Researchers at Albert Einstein College of Medicine of Yeshiva University in collaboration with Nurses' Health Study investigators have shown that levels of certain related proteins found in blood are associated with a greatly reduced risk for developing type 2 diabetes up to a decade or more later. The findings, published today in the online edition of Diabetes, could open a new front in the war against diabetes.

4 May 2012

NCIC CTG, Oncolytics to conduct REOLYSIN Phase II study in colorectal cancer

Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.

4 May 2012

Scientists discover new type of dynamic change in human stem cells

A team led by scientists at The Scripps Research Institute and the University of California (UC) San Diego has discovered a new type of dynamic change in human stem cells.

4 May 2012

JAM-A protein a far more powerful clot inhibitor: Study

Cut your toe, and platelets -- those disc-shaped cells circulating in your blood -- rush to the scene, clumping together to plug the leak. But when an unwanted clot forms in an artery, and an overaccumulation of platelets blocks blood flow, a heart attack or stroke occurs, too often with fatal results.

4 May 2012

Hypoxia may be a primary cause of uncontrollable tumor growth in cancers

Low oxygen levels in cells may be a primary cause of uncontrollable tumor growth in some cancers, according to a new University of Georgia study. The authors' findings run counter to widely accepted beliefs that genetic mutations are responsible for cancer growth.

4 May 2012